265994-70-5 Usage
Uses
Used in Pharmaceutical Industry:
2,2-dimethyl-6-nitro-2H-1,4-benzothiazin-3(4H)-one is used as an antimycobacterial agent for the development of new drugs to treat tuberculosis. Its unique ability to target the TB-causing bacteria makes it a promising candidate for the creation of more effective treatments against this disease.
Used in Drug Development:
2,2-dimethyl-6-nitro-2H-1,4-benzothiazin-3(4H)-one is utilized in the research and development of novel therapeutic agents. Its potential to inhibit the growth of Mycobacterium tuberculosis positions it as a key component in the advancement of new drug formulations aimed at combating tuberculosis, a disease that continues to pose significant health challenges worldwide.
Check Digit Verification of cas no
The CAS Registry Mumber 265994-70-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,5,9,9 and 4 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 265994-70:
(8*2)+(7*6)+(6*5)+(5*9)+(4*9)+(3*4)+(2*7)+(1*0)=195
195 % 10 = 5
So 265994-70-5 is a valid CAS Registry Number.
265994-70-5Relevant articles and documents
Highly potent 1,4-benzothiazine derivatives as KATP-channel openers
Cecchetti, Violetta,Calderone, Vincenzo,Tabarrini, Oriana,Sabatini, Stefano,Filipponi, Enrica,Testai, Lara,Spogli, Roberto,Martinotti, Enrica,Fravolini, Arnaldo
, p. 3670 - 3679 (2003)
A series of 1,4-benzothiazines, suitably functionalized at the N-4 and C-6 positions, arising from the replacement of a benzopyran-based structure of cromakalim with a 1,4-benzothiazine nucleus, has been synthesized as potassium channel openers (KCOs). Mo
Novel potassium channel openers. Part 4: Transformation of the 1,4- benzoxazine skeleton into 1,4-benzothiazine, 1,2,3,4-tetrahydroquinoline, 1,2,3,4-tetrahydroquinoxaline, indoline, and 1,5-benzoxazepine
Matsumoto, Yuzo,Tsuzuki, Ryuji,Matsuhisa, Akira,Yoden, Toru,Yamagiwa, Yoko,Yanagisawa, Isao,Shibanuma, Tadao,Nohira, Hiroyuki
, p. 393 - 404 (2007/10/03)
As part of a search for a new potassium channel opener, the 1,4- benzoxazine skeleton derived from the benzopyran skeleton of cromakalim, was transformed into other fused rings such as 1,4-benzothiazine, 1,2,3,4- tetrahydroquinoline, 1,2,3,4-tetrahydroqui